Literature DB >> 22143020

Emergency intervention for unprotected left main coronary artery stenosis: case report and review of the literature.

Jose D Burgos1, Oscar C Munoz, Debabrata Mukherjee.   

Abstract

Left main coronary artery stenosis is an important cause of symptomatic coronary artery disease, although relatively infrequent. The current guidelines recommend coronary artery bypass grafting as the first line treatment and standard of care, but percutaneous coronary intervention is likely to lead to faster reperfusion of coronary flow, avoiding the delays of a major surgical intervention. Our patient overcame cardiogenic shock after the flow of the left main coronary artery was rapidly restored through percutaneous coronary intervention and 6 days later, when hemodynamically stable, he underwent elective coronary artery bypass graft surgery. One year after the intervention, the patient has a normal functional status and an ejection fraction of 52%. This result is compatible with several small studies showing that percutaneous coronary intervention in left main coronary artery occlusions is feasible and effective, with a good short- and mid-term prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 22143020

Source DB:  PubMed          Journal:  Hellenic J Cardiol        ISSN: 1109-9666


  3 in total

1.  Association between Serum Ferritin and Circulating Oxidized Low-density Lipoprotein Levels in Patients with Coronary Artery Disease.

Authors:  Ahmadali Khalili; Amir Ghorbanihaghjo; Nadereh Rashtchizadeh; Samad Gaffari
Journal:  J Cardiovasc Thorac Res       Date:  2012-02-17

2.  Acute total occlusion of the left main coronary artery treated with percutaneous intervention and simultaneous implantation of intra-aortic balloon pump.

Authors:  Vojko Kanic; Damijan Vokac; Samo Granda
Journal:  Clin Case Rep       Date:  2017-11-08

3.  Hybrid coronary revascularization versus total arterial revascularization for the treatment of left main coronary artery disease.

Authors:  Pengxiong Zhu; Jiapei Qiu; Hong Xu; Jun Liu; Qiang Zhao
Journal:  Ann Transl Med       Date:  2021-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.